Abstract
A reverse phase-high-performance liquid chromatography-diode array detector method is developed for the determination of the antiviral drug sofosbuvir in bulk and Sofos® 400 mg tablet dosage forms. Sofosbuvir is used for the treatment of chronic hepatitis C. The separation is carried out using a gradient mobile phase consisting of 0.05% H3PO4 and acetonitrile. A symmetry C18 column (4.6 × 100 mm, 2.5 µm, Waters XSELECT HSS T3) is used with a flow rate of 1.5 mL min−1 using ultraviolet detection at 260 nm with a diode array detector and an injection loop volume of 10 µL. A sharp peak is obtained at a retention time of 14 min. The method is validated appropriately according to the requirements of the United States Pharmacopeia and the International Conference on Harmonization guideline Q2 R1. System suitability, linearity, range (1.5–4.5 µg mL−1), precision, accuracy, specificity, robustness, detection and quantification limit of the method are assured. A forced degradation study of sofosbuvir is conducted under the conditions of hydrolysis, oxidation, thermal and photolysis.
Similar content being viewed by others
References
Hassouna M, El-Kassem M, Abdelrahman M, Mohamed MA (2017) Assay and dissolution methods development and validation for simultaneous determination of sofosbuvir and ledipasvir by RP-HPLC method in tablet dosage forms. J Forensic Sci Crim Investig. https://doi.org/10.19080/JFSCI.2017.01.555562
Lavanchy D (2011) Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. https://doi.org/10.1111/j.1469-0691.2010.03432.x
ElGuennouni F (2019) Prise en charge de l’Hépatite Virale C en 2019: Place du génotypage. University of Mohamed V Rabat, Rabat
Ema Sovaldi International non-proprietary name: sofosbuvir assessment report Sovaldi. 44 (November 2013)
ICH-Guideline, Stability testing of new drug substances and products Q1A(R2). Geneva
Jayaprakash R, Natesan SK, Lalitha K (2017) Stability indicating RP-HPLC method development and validation for the simultaneous determination of vildagliptin and metformin in pharmaceutical dosage form. Int J Pharm Pharm Sci 9(3):150. https://doi.org/10.22159/ijpps.2017v9i3.16233
Nebsen M, Elzanfaly ES (2016) Stability-indicating method and LC–MS–MS characterization of forced degradation products of sofosbuvir. J Chromatogr Sci 54(9):1631–1640. https://doi.org/10.1093/chromsci/bmw119
ICH-Guideline (2005) Validation of analytical procedures: text and methodology Q2 (R1). Geneva
USP The United States Pharmacopeia 43th revision. (2020) Rockville
ICH-Guideline (2006) Impurities in new drug products Q3B. London, UK
ICH-Guideline (1997) Guidance for industry validation of analytical procedures: methodology Q2B. Rockville
CFR (2020) Current good manufacturing practice for finished pharmaceuticals part 211, vol 4. FDA, Rockville
ICH-Guideline (1996) Photo stability testing of new drug substances and products Q1B. Geneva
Acknowledgements
The corresponding authors wish to convey his sincere thanks to BEKER Laboratories LDA team for their valuable help, support, inspiration and for providing generic products and reference standards.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hamdache, A., Grib, L., Grib, C. et al. Forced Degradation Studies of Sofosbuvir with a Developed and Validated RP-HPLC Method as per ICH Guidelines. Chromatographia 84, 1131–1140 (2021). https://doi.org/10.1007/s10337-021-04099-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-021-04099-8